The Poison the Insect Has to Make: Chlorfenapyr and the Inversion of Metabolic Resistance

1. Introduction: a poison that is not one yet

This journal's article on synergists explained that insects detoxify insecticides using oxidase enzymes, that resistance frequently means producing more of them, and that a synergist restores efficacy by inhibiting them. One active turns that entirely around.

1.1 Read that against the usual case

A synergist is added to make an insecticide work better. Here it makes it work worse.³

1.2 Why the exception matters

Because the populations where this product is most useful are the ones carrying the enzymes, and the reflex to add a synergist is strongest in exactly those populations. Sections 10 to 12 are the case.

2. What the compound does

The mode of action, which is unlike anything else this journal has covered.

The active metabolite is a mitochondrial electron transport uncoupler (METU) whose mode of action is to disrupt the proton gradient across the mitochondrial membranes and impairs the production of ATP (oxidative phosphorylation) leading to cell death.¹

Stated elsewhere: the metabolite uncouples oxidative phosphorylation by disrupting the proton gradient across mitochondrial membranes, thus, resulting in disruption of production of ATP from ADP and loss of energy production leading to cell dysfunction and subsequent death of the organism.⁴

2.1 Not a nerve agent

Every other insecticide in this journal acts on a nervous system: sodium channels, acetylcholine receptors, GABA receptors, octopamine receptors. This one stops the cell making energy.¹

A reference source places it in a distinct group in the standard mode of action classification.⁶

2.2 Why an uncoupler kills

A mitochondrion generates ATP by pumping protons across its inner membrane and then allowing them back through a turbine that does the useful work. The gradient is the stored energy.

An uncoupler is a molecule that carries protons across the membrane by a different route, bypassing the turbine. The gradient dissipates, the cell burns fuel harder to rebuild it, and no ATP results. The failure is not of a signal but of the power supply.⁴

2.3 Which is the basis of the expectation

That the mode of action of chlorfenapyr differs significantly from that of standard neurotoxic insecticides, raising expectations for minimal cross-resistance issues.¹

3. The two-step mechanism

The part that makes it unusual.

It is a pro-insecticide which becomes toxic when the N-ethoxymethyl group is removed through P450-mediated oxidation. This process creates the toxic metabolite tralopyril, also known by a laboratory code.¹

A reference source states it in the same terms: oxidative removal of the N-ethoxymethyl group of chlorfenapyr by mixed function oxidases forms the compound which uncouples oxidative phosphorylation at the mitochondria, resulting in disruption of production of ATP, cellular death, and ultimately organism mortality.⁶

3.1 The dose is therefore two quantities

How much compound reaches the insect, and how much of it the insect converts. A conventional insecticide has only the first.

Which means the dose-response relationship for this active includes a term that varies with the individual, and that is our observation.

3.2 The insect performs the final synthesis

What is sprayed is a precursor. The toxin is manufactured inside the target by the target's own enzymes, which is a delivery strategy rather than a chemistry.

Our article on horizontal transfer described delayed action as the property that lets a toxicant move through a colony. This is a different reason for delay and §17 is about it.

4. Why the activation is necessary

The chemistry, which explains why it could not simply be applied in its active form.

A review notes that as an oxidative phosphorylation uncoupler, the compound should possess appropriate acidity and lipophilicity; that the parent is a lipophilic compound with an lgP value of 4.6 across a wide pH range; but that it does not demonstrate acidity before removing N-substituent group, the corresponding values for the dealkylated form being given as 5 and 7.6.⁵

4.1 The blocking group is not a mask

It is the reason the molecule is not an acid. An uncoupler works by carrying protons across a membrane, which requires a dissociable proton, and the parent does not have one.⁵

4.2 The design is deliberate

A chemist wanting a selective uncoupler has a hard problem, because the target is identical in every aerobic organism. Attaching a blocking group that only insects remove efficiently converts a universal poison into a selective one without changing the poison at all.⁵

That reading is ours and §15 is where it becomes a caution rather than an admiration.

4.3 Which is why the compound is safe to handle and lethal to eat

Or rather, to absorb and metabolise. The same review concludes that it is a precursor pesticide that only works after removing the N-ethoxymethyl groups using oxidases in insects.⁵

5. The original demonstration

The experiment that established all of this, and it used a pest this journal treats.

The parent compound caused greatly increased respiratory activity in German cockroaches but was virtually inactive as an uncoupler against isolated mitochondria. However, its N-dealkylated analog was a potent uncoupler with notable activity in the range of 10-100 nM against rat, fish, and insect mitochondria.³

5.1 The design is elegant

Give the parent to a live insect and it works. Give the parent to isolated mitochondria, which have no oxidase system attached, and nothing happens. Give the dealkylated form to the same mitochondria and it is potent.³

Three conditions, and the one that fails is the one where the activation step has been removed.

5.2 And it answers a question the field version cannot

A whole-insect bioassay tells you the compound kills. It cannot tell you whether the molecule applied is the molecule acting, because everything happens inside an animal that metabolises things.

Separating the two required taking the mitochondria out, where there is no oxidase system to perform the conversion. The isolated preparation is the control that makes the whole-animal result interpretable.³

5.3 Increased respiratory activity

Which is the diagnostic sign of an uncoupler. A cell whose proton gradient is leaking burns fuel faster and produces no additional ATP, so respiration rises while energy production falls.³

5.4 The conclusion drawn

That the parent is a propesticide that is activated by the oxidative removal of the N-ethoxymethyl group, releasing a lipophilic, weakly acidic pyrrole metabolite which exerts its toxicity through mitochondrial uncoupling.³

6. The synergist result

The finding from §1, in its place.

Both respiratory stimulation and toxicity were antagonized in insects by pretreatment with the monooxygenase inhibitor piperonyl butoxide.³

6.1 Both, which is the point

The respiratory sign and the mortality moved together and both were reduced by inhibiting the oxidase.³ That is one mechanism producing two observable effects, and blocking the mechanism removes both.

6.2 Confirmed later in a second insect

A review reports that the same inhibitor significantly reduced the toxicity of chlorfenapyr against the potato leaf beetle.⁵

7. And the control that confirms it

The detail that makes the result airtight.

The same review states that the inhibitor had no effect on the active metabolite.⁵

7.1 Which rules out the alternative explanation

If the inhibitor were simply interfering with uptake, distribution or the target, it would reduce the toxicity of both forms. It reduces only the parent's, which places the interference precisely at the activation step.⁵

7.2 This is a well-established active

We want to be clear that none of this is contested. The two-step mechanism, the identity of the metabolite and the synergist antagonism are all standard and appear across every source we read.¹³⁵

8. Which enzymes do it

Named, in a study whose framing is the interesting part.

Researchers investigated chlorfenapyr metabolism by a panel of eight P450s commonly associated with pyrethroid resistance in two mosquito vectors, finding it activated to tralopyril by four named enzymes.¹

8.1 Four of eight

Which is worth stating precisely: half the panel activated the compound and half did not.¹

So the relationship between pyrethroid resistance and susceptibility to this active is not automatic. It depends on which enzyme is elevated, and that observation sets up §9.

8.2 Commonly associated with pyrethroid resistance

The panel was selected because these are the enzymes that make mosquitoes resistant to pyrethroids. Four of the eight activate chlorfenapyr.¹

8.3 The authors' framing

That pyrethroid resistance is often associated with elevated levels of chemoprotective P450s with broad substrate specificity, which could influence chlorfenapyr activity.¹

Could influence is the careful phrasing. The direction of the influence is the subject of §10.

9. And how much they differ

The kinetics, which matter more than they look.

The catalytic efficiency of 0.66 for one enzyme was 6.7 fold higher than two others (both 0.1) and 22-fold higher than a fourth (0.03).¹

9.1 Twenty-two fold between two enzymes

Both of which confer pyrethroid resistance, and both of which activate this compound.¹

9.2 Which predicts variable performance

Two populations with equal pyrethroid resistance, arising through different enzymes, would convert this pro-insecticide at rates differing by more than an order of magnitude.

So the compound's efficacy against a resistant population depends on which resistance mechanism that population has, which is a considerably more specific requirement than any monitoring programme this journal has described. That inference is ours, and the paper's title refers to identifying potential activation markers, which suggests the authors see the same implication.¹

10. The inversion

Assembling the argument.

In the ordinary case an oxidase encountering an insecticide destroys it, resistance consists of having more oxidase, and the countermeasure is to inhibit the oxidase.

Here the oxidase encountering the compound creates the toxin. More oxidase means faster activation. Inhibiting it removes the toxicity.³⁵

10.1 With one important qualification

An enzyme that activates a compound can also degrade it. A P450 that performs the N-dealkylation may go on to oxidise the metabolite further, and whether the net effect of high enzyme activity is more toxin or less depends on the balance of those rates.

The paper reporting the kinetics measured formation of the active metabolite rather than its subsequent fate,¹ so the balance is not something we can state. The inversion is real in direction and its magnitude is not established.

10.2 Every term reverses

The enzyme that was the problem is the mechanism. The resistance trait becomes a susceptibility trait. The synergist becomes an antagonist.

We have not seen this stated as a single reversal anywhere and offer it as our framing.

11. What this journal has said about synergists

Being specific about what needs correcting.

Our synergists article described piperonyl butoxide as the standard countermeasure to metabolic resistance, and our minimum risk article noted that essential oil constituents inhibit the same enzyme systems and are therefore candidate synergists. Both discussions assumed inhibition is helpful.

11.1 Why we did not catch it then

Because the synergist literature is written about detoxification and says so, and a reader who has not encountered a pro-insecticide has no reason to ask whether the generalisation has exceptions.

Which is the ordinary way a correct statement about a class becomes an incorrect statement about everything, and this journal has made that error at least once before.

11.2 That assumption holds for most actives

Pyrethroids, carbamates and organophosphates are all detoxified rather than activated, and for those the argument stands unchanged.

11.3 It does not hold for this one

Which we should have said, and are saying now.³⁵

12. Which is now a warning

The practical form.

Do not synergise this product. A pyrethroid formulation containing piperonyl butoxide applied to the same surface, or in sequence with overlapping residues, inhibits the enzyme this compound requires.³

12.1 The realistic scenario

A technician treats for a pyrethroid-resistant population, reaches for a synergised pyrethroid because our own synergists article recommends exactly that, and follows it with a chlorfenapyr application to the same harbourage.

That is a defensible sequence under every other article in this journal and an incoherent one here.

12.2 And the same caution applies to botanicals

Our minimum risk article found that essential oil constituents inhibit the same oxidase systems, and framed that as their most defensible use. Applied alongside this compound, the same property works against it.

Which is a narrower warning than the synergist one because the inhibition is weaker, and it follows from the same mechanism.

12.3 We have no data on the magnitude

Whether a residual synergist deposit persists at a concentration sufficient to matter in the field is not something any source we read addresses. The laboratory result used deliberate pretreatment.³

So this is a mechanistic caution rather than a demonstrated field effect, and §24 repeats that.

13. The cross-resistance expectation

What the literature reports about resistance to other classes.

One review states that the compound shows low interactive resistance to carbamate, organophosphorus, and pyrethroid insecticides.⁵

Multiple studies assessed cross-resistance patterns in multiply resistant strains of two mosquito genera.²⁴

13.1 What cross-resistance testing actually measures

Both mosquito studies assessed cross-resistance in strains already resistant to multiple other classes.²⁴ A strain surviving several chemistries and dying normally to a new one is the standard evidence that the new one is independent.

The limitation is that such a test reports the net result without separating target-site from metabolic resistance in the strain, and §13.2 turns on that distinction.

13.2 Which is the expected result for a different target

Target-site resistance to a sodium channel modifier confers nothing against a compound that acts on mitochondria.¹

13.3 And metabolic resistance runs the other way

Where resistance to the other classes is metabolic rather than target-site, the elevated enzymes should increase rather than decrease susceptibility to this compound.¹

Which is the strongest possible form of no cross-resistance, and it is our reading rather than a claim any source makes directly.

14. And the structural pest case

Where this matters in our work.

The compound is described as used commercially for termite control and crop protection.² The original characterisation used German cockroaches.³

14.1 Bed bugs are the obvious application

Our article on layered resistance in bed bugs described populations carrying both target-site and metabolic resistance to pyrethroids, with elevated detoxification enzymes among the mechanisms involved.

Those are precisely the populations in which a compound requiring oxidase activation should perform well, and §13.2 is why. That is our inference and we found no bed bug study testing it.

14.2 And the cockroach case is already half answered

The original characterisation used German cockroaches and the parent worked on them,³ which establishes that this species performs the activation. Whether the field populations our German cockroach articles describe, carrying substantial metabolic resistance, perform it faster is the open question.

14.3 Which would be worth testing

A straightforward comparison: susceptibility to this compound in pyrethroid-resistant against pyrethroid-susceptible strains, with the resistance mechanism characterised.

15. Where the selectivity lives

The uncomfortable observation.

The active metabolite is a potent uncoupler with notable activity in the range of 10-100 nM against rat, fish, and insect mitochondria.³

15.1 Rat, fish and insect alike

Mitochondria are mitochondria. The proton gradient works the same way in a beetle and in a mammal, and the metabolite does not distinguish.³

15.2 It is not even selective between phyla

A rat, a fish and an insect are separated by hundreds of millions of years, and the same molecule at the same concentration range works on all three.³ Mitochondrial energy coupling is among the most conserved machinery in biology, which is exactly why it makes a poor selective target and a very effective non-selective one.

15.3 So the selectivity is entirely in step one

The compound is safe to a mammal to the extent that a mammal does not efficiently perform the N-dealkylation that insects perform. Nothing downstream of that provides any margin.

That is our conclusion from the two facts and it is the most important thing in this article.

16. What that means for the safety margin

Being careful here.

One source reports that this molecule has low mammalian toxicity and is classified as slightly hazardous insecticide under a global health body's criteria.⁴

16.1 Which is a regulatory finding and we accept it

The classification is based on toxicity testing of the compound as applied, which is the form anybody is exposed to.⁴

16.2 The point is where the margin comes from

Not from a target that mammals lack, which is the selectivity argument for most modern insecticides and the one our repellent and RNA-based pesticide articles described. From a metabolic difference.

We are not suggesting the product is unsafe. We are noting that its safety rests on a single step and that an article explaining a mode of action should say which step.

16.3 Which is a different argument from the usual one

Most modern insecticide selectivity rests on a receptor difference: the insect nicotinic receptor differs from the mammalian one, the insect octopamine receptor has no mammalian equivalent. Those margins are structural and do not depend on what the mammal does.

A margin resting on a metabolic difference depends on the metabolism, which varies between species, between individuals and with anything else that alters enzyme activity.

That comparison is ours and we are not aware of it being raised as a concern about this compound.

16.4 And the fish entry is not incidental

The same sentence names fish mitochondria.³ Aquatic toxicity is a predictable consequence and our pollinator exposure article describes the general problem of non-target effects from a structural application.

17. The delay

An operational property that follows from the mechanism.

Two things have to happen before the insect dies: the compound must be absorbed and dealkylated,¹ and the resulting energy failure must accumulate to the point of cell death.⁴

17.1 Neither is fast

A nerve agent produces symptoms in minutes because it interrupts signalling. An energy failure kills when reserves are exhausted, which depends on the insect's metabolic state and activity level.

That reasoning is ours and it predicts variable and slow mortality rather than knockdown.

17.2 And it predicts a specific failure mode

An insect that is inactive, cool or metabolically slow uses less ATP and should therefore tolerate a partial energy failure for longer.

Which would make efficacy temperature-dependent in a way that a nerve agent's is not, and in this climate that is a January question rather than an academic one. We found no data on it and it is our speculation.

17.3 Which is a feature in some settings

Our horizontal transfer article established that a toxicant killing too quickly cannot be carried back to a harbourage. Delay is a requirement for that route and a liability where a client wants a visible result.

18. What resistance would look like

The prediction this article exists to make.

If susceptibility depends on the insect performing an activation step, then resistance would most plausibly consist of doing less of it.

18.1 Which is reduced oxidase activity

Or a change in the specific enzymes that perform this particular oxidation, given the twenty-two fold difference between them in §9.¹

18.2 And that is the opposite of pyrethroid resistance

Which consists of elevated oxidase activity.¹

A population selected for resistance to this compound should therefore become, other things being equal, more susceptible to the compounds its enzymes previously destroyed.

18.3 And a fitness cost argument attaches to it

Our reversion article found that resistance alleles carrying a fitness cost decline when selection stops, and that several mechanisms prevent that decline in practice.

Reduced oxidase activity would carry an obvious cost, since those enzymes exist to handle the plant toxins and environmental compounds an insect encounters. Which suggests resistance of this kind would be more reversible than most, and is a second prediction from the same premise.

18.4 We are aware this is a strong claim

It is ours, it follows from the mechanism rather than from any reported observation, and we found no study of chlorfenapyr resistance mechanisms in this search. Section 19 is how it could be checked.

19. And why that is testable

Because the prediction is specific.

Select a population on this compound, then measure its susceptibility to a pyrethroid and its oxidase activity. The prediction is that resistance to the first is accompanied by reduced enzyme activity and increased susceptibility to the second.

19.1 A negative would be informative too

If resistance arises by an entirely different route, such as target-site change in the mitochondrial membrane or reduced penetration, the prediction fails and the mechanism is more complex than the activation story suggests.

19.2 And there is a reason it may not have been asked

Resistance monitoring is organised around measuring whether a population survives a diagnostic dose. It is built to detect resistance, not to characterise what resistance to a particular compound consists of.

Our resistance monitoring article made that point about diagnostic dose assays generally, and this is a case where the mechanism question has a practical answer attached to it rather than only an academic one.

19.3 This journal's usual complaint does not apply here

We normally end by noting that nobody has measured the thing. In this case the measurement is cheap, the prediction is falsifiable and the compound is in current use, which is a better position than most subjects we cover.

20. The combination products

How the compound is actually deployed in vector control.

It is increasingly used in combination with pyrethroids such as a-cypermethrin or deltamethrin in insecticide treated bednets to control malaria transmitted by pyrethroid-resistant mosquito populations.¹

20.1 Which is the right combination

A pyrethroid to affect susceptible individuals and this compound to affect the metabolically resistant ones, whose enzymes activate it. The two components target opposite halves of a mixed population.

That reading is ours and it is why the combination is more than a hedge.

20.2 It also hedges the activation problem

Section 8.1 records that only four of eight resistance-associated enzymes activated the compound. A population whose resistance runs through one of the other four would be resistant to the pyrethroid and poorly served by the partner.¹

Which is an argument for the combination and against relying on the partner alone, and is ours.

20.3 And our malaria article's connection

That article described a treated bed net as an intervention that does not depend on the vector resting on a wall, and recorded that a health body found nets more cost-effective than spraying in high transmission areas. This is what the current generation of those nets contains.¹

20.4 The one combination to avoid

A synergised pyrethroid, per §12.³

21. What a contractor should take from this

Four points.

Read the label for a synergist. A pyrethroid product containing piperonyl butoxide is chemically opposed to this one, and the interaction is not obvious.³

Expect slow action and tell the client. Section 17. A client who judges the treatment at day two will judge it wrong.

It is a good candidate where pyrethroids have failed metabolically. Which is most of the bed bug work described in our resistance articles.¹

And the label directions are the safety margin. Section 15 establishes that the metabolite is not selective, so exposure control rather than target specificity is what protects people.

21.1 Which is a general point about mode of action knowledge

None of the four follows from the label. A label states what to apply, where, at what rate and with what precautions, and our label article established that those directions carry legal force. None of them says that a synergist antagonises the product or that the safety margin sits in a metabolic step.

Which is the argument for a technician understanding mechanism rather than only instructions, and it is the argument our certification article found the evidence for thinner than expected. This article is a worked example of what the knowledge buys.

22. And what we would not claim

Three limits.

That it is resistance-proof. Nothing is, and our reversion article found that every chemistry eventually meets a population that survives it.

That the synergist interaction has been demonstrated in the field. It has been demonstrated in laboratory pretreatment experiments.³

And that the prediction in §18 is established. It is a hypothesis with a clear test and no result.

23. The Manitoba position

Brief.

Registration status for any particular product in Canada is a matter for the federal regulator and the label, which our registration and label articles describe, and we are not stating what is registered here.

23.1 The local relevance

Sits entirely in bed bugs. Our layered resistance article and our bed bug pricing article both describe a control problem driven by pyrethroid failure, and an active whose efficacy may be enhanced by the resistance mechanism is worth knowing about for that reason alone.

23.2 And the absent measurement

Which resistance mechanisms predominate in Winnipeg bed bug populations. Our molecular diagnostics article identified that gap, and §9.2 shows it would now determine the choice of product rather than only explaining a failure.

24. Limitations and open questions

Most of the evidence is from mosquitoes. The enzyme panel, the kinetics and the cross-resistance work are all vector control.¹²⁴

The original demonstration reaches us secondhand. The cockroach and isolated mitochondria results are quoted within a later paper's discussion rather than read in the original.³

One source is tertiary. The mode of action classification and the chemical naming come from a general reference compilation, flagged accordingly.⁶

We found no structural pest efficacy data. No bed bug, cockroach or ant trial results, no application rates and no residual duration figures on building substrates.

The synergist warning is mechanistic. Section 12.2 says so.

And the resistance prediction is untested. Section 18.3 says so.

Sections 1.1, 3.1, 4.1, 5.1, 5.2, 9.2, 10.1, 12, 13.2, 14.1, 15.2, 16.2, 17, 18, 19, 20.1 and 21 are our reasoning. The inversion framing, the reading of the blocking group's chemical role, the interpretation of the isolated mitochondria design, the prediction about which resistance mechanism determines efficacy, the synergist warning, the location of the selectivity, the delay argument and the resistance prediction are ours rather than sourced positions.

25. Conclusion

What is applied is not the poison. A pyrrole carrying an N-ethoxymethyl group is lipophilic and not acidic, and an uncoupler has to be both; the insect's own oxidases remove that group, which creates the acid, and the resulting metabolite collapses the proton gradient across mitochondrial membranes until the cell cannot make ATP.⁵¹ The demonstration was clean: the parent raised respiration in German cockroaches and did nothing to isolated mitochondria, while the dealkylated form was potent at ten to a hundred nanomolar, and both the respiratory effect and the mortality were abolished by pretreating the insects with an oxidase inhibitor.³

That inhibitor is piperonyl butoxide, which this journal's article on synergists recommended as the standard countermeasure to metabolic resistance. For this active it is an antagonist, and the reversal is complete: the enzymes that confer resistance to pyrethroids activate this compound, four of eight such enzymes tested were shown to do it, and their catalytic efficiencies differed by twenty-two fold, so which resistance mechanism a population carries determines how well the product works on it.¹

Two things follow that we have not seen stated. The selectivity is located entirely in the activation step, since the metabolite uncouples rat, fish and insect mitochondria alike, which means the margin comes from a metabolic difference rather than from a target mammals lack. And resistance to this compound, when it arrives, should consist of doing less of the activation rather than more of the detoxification, which would make a resistant population more susceptible to the chemistry it previously survived. That is a falsifiable prediction, the test is inexpensive, and nobody appears to have run it.

References

1. Chlorfenapyr metabolism by mosquito cytochrome P450s associated with pyrethroid resistance identifies potential activation markers. Open-access journal article in a general science title. Used for the statement that chlorfenapyr is a pro-insecticide increasingly used in combination with named pyrethroids in insecticide treated bednets to control malaria transmitted by pyrethroid resistant mosquito populations; for the account that it becomes toxic when the N-ethoxymethyl group is removed through P450-mediated oxidation, creating the toxic metabolite named in the paper; for the description of that metabolite as a mitochondrial electron transport uncoupler whose mode of action is to disrupt the proton gradient across mitochondrial membranes and impair the production of ATP, leading to cell death; for the observation that its mode of action differs significantly from standard neurotoxic insecticides, raising expectations for minimal cross-resistance; for the study design investigating metabolism by a panel of eight P450s commonly associated with pyrethroid resistance in two named vector species, with the compound activated by four named enzymes; for the reported catalytic efficiency of 0.66 per micromolar per minute for one enzyme, 6.7-fold higher than two others at 0.1 each and 22-fold higher than a fourth at 0.03; and for the framing that pyrethroid resistance is often associated with elevated levels of chemoprotective P450s with broad substrate specificity, which could influence chlorfenapyr activity. https://pmc.ncbi.nlm.nih.gov/articles/PMC10465574/
2. Chlorfenapyr: a new insecticide with novel mode of action can control pyrethroid resistant malaria vectors. Open-access journal article in a malaria title. Used for the statement that malaria vectors have acquired widespread resistance to many currently used insecticides including synthetic pyrethroids, creating an urgent need for alternatives; for the study design evaluating residual efficacy and persistence on different substrates against susceptible strains of two named Anopheles species, assessing cross-resistance patterns in laboratory-reared multiply resistant strains and in field-collected material from two named Indian states, and undertaking potentiation studies with a known mixed function oxidase inhibitor to assess synergism or antagonism; for the laboratory conditions maintained during the studies; and for the statement that chlorfenapyr is used commercially for termite control and crop protection against a variety of insect and mite pests. https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-10-16
3. Research repository record for the malaria journal article, reproducing the abstract together with the earlier mode-of-action characterisation it discusses. Repository listing rather than the primary source for the older work, flagged accordingly. Used for the account that the parent compound caused greatly increased respiratory activity in German cockroaches but was virtually inactive as an uncoupler against isolated mitochondria, while its N-dealkylated analogue was a potent uncoupler with notable activity in the range of 10 to 100 nanomolar against rat, fish and insect mitochondria; for the finding that both respiratory stimulation and toxicity were antagonised in insects by pretreatment with the monooxygenase inhibitor piperonyl butoxide; for the note that structure-activity studies with a range of halogenated pyrroles supported a relationship between uncoupling and toxicity; and for the conclusion that the parent is a propesticide activated by oxidative removal of the N-ethoxymethyl group, releasing a lipophilic, weakly acidic pyrrole metabolite which exerts its toxicity through mitochondrial uncoupling. https://www.researchgate.net/publication/49784503_Chlorfenapyr_A_new_insecticide_with_novel_mode_of_action_can_control_pyrethroid_resistant_malaria_vectors
4. Evaluation of the pyrrole insecticide chlorfenapyr for the control of a named mosquito species. Journal article in a tropical medicine title, read as abstract. Used for the description of the compound as a pyrrole class insecticide and pro-insecticide converted to an active metabolite by the action of mixed function oxidase; for the statement that the metabolite uncouples oxidative phosphorylation by disrupting the proton gradient across mitochondrial membranes, disrupting production of ATP from ADP and causing loss of energy production leading to cell dysfunction and death; for the study design determining diagnostic dosage, residual efficacy and persistence on artificially fabricated substrates against multiply resistant strains, with cross-resistance assessment and potentiation studies using a named oxidase inhibitor to assess synergism or antagonism; and for the statements that the compound was at the time registered in nineteen countries for control of insect and mite pests on named crops, has low mammalian toxicity and is classified as a slightly hazardous insecticide under a global health body's criteria. https://www.sciencedirect.com/science/article/abs/pii/S0001706X1100026X
5. A comprehensive review of the current knowledge of chlorfenapyr: synthesis, mode of action, resistance and environmental toxicology. Open-access review article. Used for the account that the compound damages mitochondria by disturbing the proton gradient in the mitochondrial membrane and inhibiting the conversion of ADP to ATP, causing cell death; for the statement that as an oxidative phosphorylation uncoupler the compound should possess appropriate acidity and lipophilicity, that chlorfenapyr is lipophilic with a stated partition coefficient across a wide pH range, but that it does not demonstrate acidity before removal of the N-substituent group, with stated partition coefficient and acid dissociation values for the proton-type form; for the conclusion that it is a precursor pesticide that only works after removal of the N-ethoxymethyl group using oxidases in insects; for the report that the microsomal monooxygenase inhibitor piperonyl butoxide significantly reduced the toxicity of chlorfenapyr against a named beetle but had no effect on the active metabolite; for the list of crop and horticultural pests the compound controls effectively; and for the statement that it shows low interactive resistance to carbamate, organophosphorus and pyrethroid insecticides. https://pmc.ncbi.nlm.nih.gov/articles/PMC10675257/
6. Chlorfenapyr, general reference compilation entry. Tertiary source, flagged accordingly. Used for the summary that oxidative removal of the N-ethoxymethyl group by mixed function oxidases forms a named compound, which uncouples oxidative phosphorylation at the mitochondria resulting in disruption of ATP production, cellular death and ultimately organism mortality; and for the placement of the active in a distinct numbered group of the standard industry classification of insecticide modes of action. https://en.wikipedia.org/wiki/Chlorfenapyr